🇺🇸 FDA
Pipeline program

CSII

13560475186

Approved small_molecule completed

Quick answer

CSII for Diabetes Mellitus, Type 2 is a Approved program (small_molecule) at The First People's Hospital of Lianyungang with 1 ClinicalTrials.gov record(s).

Program details

Company
The First People's Hospital of Lianyungang
Indication
Diabetes Mellitus, Type 2
Phase
Approved
Modality
small_molecule
Status
completed

Clinical trials